Trials / Completed
CompletedNCT00712920
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 and MP03-33 in Patients With Perennial Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 581 (actual)
- Sponsor
- Meda Pharmaceuticals · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if two allergy medications are more effective than placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.15% azelastine hydrochloride | 0.15% azelastine hydrochloride 1644 mcg |
| DRUG | 0.1% azelastine hydrochloride | 0.1% azelastine hydrochloride 1096 mcg |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2008-05-01
- First posted
- 2008-07-10
- Last updated
- 2011-06-08
- Results posted
- 2010-01-15
Locations
43 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00712920. Inclusion in this directory is not an endorsement.